Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

HYDRALAZINE 100 MG TABLET

hydralazine hydrochloride
$0.0761per EA

Strength

100 mg/1

Manufacturer

Modavar Pharmaceuticals LLC

NDC

72241000605

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

HYDRALAZINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203845

On Market Since

12/29/2015

Pharmacological Classes

Arteriolar Vasodilation
Arteriolar Vasodilator

Price History

1W

0.0%

1M

-0.6%

3M

+0.7%

6M

-4.0%

1Y

-6.3%

3Y

N/A

5Y

N/A

All

-8.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

HYDRALAZINE 10 MG TABLET
Generic
00904744761•Major Pharmaceuticals
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
23155083201•Heritage Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
23155083210•Heritage Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
31722051901•Camber Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50111039801•Teva Pharmaceuticals USA Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50111039803•Teva Pharmaceuticals USA Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50228018201•ScieGen Pharmaceuticals, Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50228018210•ScieGen Pharmaceuticals, Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
51079007420•Mylan Institutional LLC
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
60687081101•American Health Packaging
$0.0270
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy